Starting January 15, most people with a commercial health plan will be able to receive at-home over-the-counter COVID-19 diagnostic tests authorized by the U.S. Food and Drug Administration (FDA) at no cost, either through reimbursement or free of charge through their insurance. This applies whether you purchased your health plan on your own or whether you get health insurance through your job. Check out this FAQ document from CMS for more information. State Medicaid and Children’s Health Insurance Program (CHIP) programs are currently required to cover FDA-authorized at-home COVID-19 tests without cost-sharing.
This Department of Labor FAQ offers more details as to diagnostic testing and related issues under the ACA Implementation of the Families First Coronavirus Act.
Comments